Welcome to LookChem.com Sign In|Join Free

CAS

  • or

328918-90-7

Post Buying Request

328918-90-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

328918-90-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 328918-90-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,2,8,9,1 and 8 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 328918-90:
(8*3)+(7*2)+(6*8)+(5*9)+(4*1)+(3*8)+(2*9)+(1*0)=177
177 % 10 = 7
So 328918-90-7 is a valid CAS Registry Number.

328918-90-7Downstream Products

328918-90-7Relevant articles and documents

Oxazolyl-aryloxyacetic acid derivatives and their use as ppar agonists

-

, (2008/06/13)

Compounds represented by the following (I), and pharmaceutically acceptable salts, solvates and hydrates thereof, wherein R1 is an unsubstituted or substituted aryl, heteroaryl, cycloalkyl, aryl-alkyl, heteroaryl-alkyl or cycloalkyl-alkyl, R2 is H, alkyl or haloalkyl, the polymethylene chain (II), is saturated or may contain a carbon-carbon double bond, while n is 2, 3, 4, W is O or S, Y is an unsubsituted or substituted phenylene, naphthylene or 1, 2, 3, 4 tetrahydronaphthylene, R3 is H, alkyl or haloalkyl. R4 is H, alkyl, haloalkyl or a substituted or unsubstituted benzyl, are useful for modulating a peroxisome proliferator activated receptor, particularly in the treatment of diabetes mellitus.

Design and synthesis of 2-methyl-2-{4-[2-(5-methyl-2-aryloxazol-4-yl)ethoxy]phenoxy}propionic acids: A new class of dual PPARα/γ agonists

Brooks,Etgen,Rito,Shuker,Dominianni,Warshawsky,Ardecky,Paterniti,Tyhonas,Karanewsky,Kauffman,Broderick,Oldham,Montrose-Rafizadeh,Winneroski,Faul,McCarthy

, p. 2061 - 2064 (2007/10/03)

Propionic acid derivative 8, which was designed and synthesized based on putative pharmacophores of known PPARγ- and PPARα-selective compounds, exhibits potent dual PPARα/γ agonist activity as demonstrated by in vitro binding and dose overlap in the newly

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 328918-90-7